Effectiveness of KeraStat Gel for Improved Cosmesis of Partial Thickness Burns

Partial-thickness Burn Clinical Trial

Official title: Effectiveness of KeraStat Gel for Improved Cosmesis of Partial Thickness Burns

Status Recruiting

Clinical Trial Summary

A randomized, controlled, 30-subject, within-subject trial for examining the effectiveness of KeraStat Gel, as opposed to the institutional standard of care, silver sulfadiazine, in improving cosmesis of the healed wound.

Clinical Trial Description

The study seeks to determine whether the use of KeraStat Gel as the primary dressing for partial thickness burns results in improved cosmesis of the healed wound, and results in less painful dressing changes, faster reepithelialization, and reduction in need for excision and grafting. The study will enroll 30 subjects. The study design is a randomized, controlled, within-subject trial to compare the effectiveness of KeraStat Gel vs. standard of care (SOC), silver sulfadiazine (SSD). Each of two distinct burns will be randomized to the use of KeraStat Gel or SOC. Patients will be seen weekly for the first month and then at months 3, 6, and 12 post burn. ;

Related Conditions & MeSH terms

• Burns
• Partial-thickness Burn

• NCT number: NCT03564795
• Study type: Interventional
• Source: KeraNetics, LLC
• Contact: Alexis Rejeski Gabard, MS
• Phone: 336-575-2278
• Email: alexis.gabard@keranetics.com
• Status: Recruiting
• Phase: N/A
• Start date: August 31, 2018
• Completion date: October 31, 2022